# Infant Bacterial Therapeutics – aktieanalysens källarkiv Company page: https://spela.port0.org/company/infant-bacterial-therapeutics Company JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/company.json Documents JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/documents.json Updated: 2026-08-07T04:15:59Z ## Market data - Nasdaq kurshistorik CSV: https://spela.port0.org/company/infant-bacterial-therapeutics/market/history.csv - Nasdaq kurshistorik JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/market/history.json - Nasdaq manifest JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/market/manifest.json - Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/market/instrument.json - MFN manifest JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/market/mfn-manifest.json - Nasdaq rapportmanifest JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/market/nasdaq-reports-manifest.json ## Financial reports - Page: https://spela.port0.org/company/infant-bacterial-therapeutics/reports - JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/reports/reports.json - 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b027354d8e44a5d55bc4685ce60a31680&lang=sv&src=listed - 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=bb79125e01308503d8fb0682efb0e64c0&lang=sv&src=listed - 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b000eddc922590847a6e3ee0d56221b3f&lang=sv&src=listed - 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=bc6cede42db1d7a976b2e88e76bbfd15a&lang=sv&src=listed - 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b3b6d7c8e695faa8f16d807ea4db5b340&lang=sv&src=listed - 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b7812a17f37d874ba0372929cb127d527&lang=sv&src=listed - 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=bdada50e058b5762e4fb9f8442f6ecf8a&lang=sv&src=listed - 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b219653b47b21d8d37022e6efc14f4497&lang=sv&src=listed - 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=be2a184557531627f12b4c743e4162be9&lang=sv&src=listed - 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=b879b094182889bce0984b3e5d04e5f11&lang=sv&src=listed - 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=b7d0f45700fa593a9e0b100e952ba66f4&lang=sv&src=listed - 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=ba67f73ce2150c6f2b071c09711935ca8&lang=sv&src=listed - 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=b2c256b9cecd4622a19b3fb7f0696c6e7&lang=sv&src=listed - 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b7670857707eac3635c8c61428b078d49&lang=sv&src=listed - 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b40d0cf9c5bfd2045fc4f738fb5be832e&lang=sv&src=listed - 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=bf428a2811566892e1897cbddae12e0ec&lang=sv&src=listed ## Finansinspektionen - Page: https://spela.port0.org/company/infant-bacterial-therapeutics/finansinspektionen - Summary: https://spela.port0.org/company/infant-bacterial-therapeutics/finansinspektionen/summary.json - Insider transactions CSV: https://spela.port0.org/company/infant-bacterial-therapeutics/finansinspektionen/insider-transactions.csv - Insider transactions JSON: https://spela.port0.org/company/infant-bacterial-therapeutics/finansinspektionen/insider-transactions.json - Current short positions: https://spela.port0.org/company/infant-bacterial-therapeutics/finansinspektionen/short-current.json - Historical short positions: https://spela.port0.org/company/infant-bacterial-therapeutics/finansinspektionen/short-history.json ## Full-text source documents - Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt - Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt - Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt - Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt - Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt - MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/infant-bacterial-therapeutics/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt